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Introduction
Chronic alcohol drinking, nonalcoholic steatohepatitis, viral hepatitis are the 3 major causes of chronic liver injury worldwide, causing end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. (46) Currently, the only effective treatment for these end-stage diseases is liver transplantation. Of note, due to the liver's unique immunologic properties, the rejection rate for liver transplantation is lower compared with transplantation with other organs. (1, 39, 40) The liver's immune system is predominantly innate; enriched with innate immune cells such as Liver lymphocytes are enriched in NK cells: approximately 5-10% in mice and 30-50% in rats and humans. (9, 15, 36) Not only do NK cells play a pivotal role in host defenses against pathogen invasion and tumor transformation, they are also involved in liver injury and repair. (11) In several different experimental models, NK cells have been shown to contribute to liver injury and inhibit liver fibrosis. (3, 10, 29, 33, 37) Studies have also shown that activated NK cells can directly kill hepatocytes or activated hepatic stellate cells via TRAIL-and NKG2D-dependent mechanisms. (3, 10, 29, 33, 37) In addition, NK cell activation inhibits liver regeneration by blocking hepatocyte and oval cell proliferation in an IFN--dependent manner. (18, 41) NK cell activation produces IFN-, which targets hepatocytes by binding to IFN-receptors and activates the signal transducer and activator of transcription 1 (STAT1) signaling pathway. Activation of STAT1 induces cell cycle arrest and apoptosis in hepatocytes, thereby suppressing liver regeneration. (6, 42) In contrast to STAT1, activation of STAT3 appears to promote liver regeneration. (17, 27, 31, 47) In this investigation, we examined the role of NK/IFN-on liver injury and hepatocyte proliferation in allogeneic and syngeneic orthotopic liver transplantation (OLT) models, where NK/IFN-is strongly activated in the allogeneic grafts, but not in the syngeneic grafts. There are Page 3 of 25 two well-established models of allogeneic OLT: the spontaneous acceptance model of Lewis-to-DA rat liver transplants and the rejection model of DA-to-Lewis rat liver transplants. Livers transplanted from DA to Lewis rats are rejected within 9 to 12 days followed by resulting in death, but conversely, Lewis-to-DA liver transplants result in tolerance and survival. (12, 32) The mechanisms underlying tolerance of Lewis-to-DA liver transplants remain poorly understood.
Previously, it was reported that in the Lewis-to-DA model, there is marked lymphocyte proliferation and infiltration, but it is unclear why this immune response does not lead to graft rejection.(2, 39) Our findings from this investigation reveal that although more liver injury was observed with the allogeneic (Lewis-to-DA) grafts compared with the syngeneic grafts, hepatocyte proliferation was lower in the allogeneic grafts. Compared with the syngeneic gratfts, higher levels of IFN-/STAT1 activation were detected in the allogeneic grafts. Depletion of NK cells decreased IFN-/STAT1 activation, but enhanced hepatocyte proliferation, suggesting that NK/IFN-is likely involved in decreased hepatocyte proliferation in the allogeneic grafts.
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Materials and Methods
Animals: Inbred male Lewis and Dark Agouti (DA) rats weighing 220-260g were purchased from Harlan (Indianapolis, IN). All animals were kept in a temperature-controlled environment with a 12-hour light-dark cycle and were allowed free access to food and water at all times, and were cared for in accordance with National Institutes of Health (NIH) guidelines. Western blotting. Liver tissues were homogenized in protein lysis buffer (30 mM Tris, PH 7.5, 150 mM sodium chloride, 1 mM sodium orthovanadate, 1% Nonidet P-40, 10% glycerol, and phosphatase and protease inhibitors). Western blot analyses were performed using 60 µg of protein from liver homogenates using STAT1, STAT3, p-STAT1, p-STAT3 antibodies (1:1000 dilution, Cell Signaling Technology, Danvers, MA).
Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST). Serum levels of ALT
and AST were measured using a kit from Drew Scientific Ltd (Barrow-in-Furness, UK).
Enzyme-linked immunosorbent assay (ELISA). Serum levels of IFN-H were measured using an
ELISA kit (BioSource International, Camarillo, CA). All serum samples were analyzed in triplicate. This assay was determined to have a sensitivity of 10 pg/mL using recombinant rat IFN-H as a standard (BioSource). and DA-L groups on day 3, 5, and 7 post-transplant compared with the L-L group. Similar to previous reports, (22, 30) we also observed significantly increased numbers of apoptotic lymphocytes in the allogeneic grafts. As this paper is mainly focused on hepatocyte proliferation and injury, the number of apoptotic lymphocytes was not counted in this paper.
Depletion of NK cells
Hepatocyte proliferation is lower in the allogeneic grafts vs. the syngeneic grafts
Hepatocyte proliferation was determined by immunostaining with Ki-67 or PCNA antibodies.
Results shown in Fig. 2 reveal that peak Ki-67 staining occurred on day 3 after transplantation in all 3 groups, with the highest in the L-L group (approximately 12%), but only 2-5% in the L-DA and DA-L groups. Similarly, peak PCNA staining was also observed on day 3 post transplant in all 3 groups, with the most staining detected in the L-L group.
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Upregulation of STAT1 activation and downregulation of STAT3 in the allogeneic grafts vs.
the syngeneic grafts
The STAT3 protein has been implicated in promoting liver regeneration, while STAT1 has been implicated in inhibition of liver regeneration. (6, 17, 27, 31, 42, 47) To define the molecular mechanism by which liver regeneration is suppressed in allogeneic grafts, we examined STAT1
and STAT3 activation in all 3 groups. As shown in Figs. 3A-B, low levels of STAT1 activation was detected in syngeneic grafts, with peak activation on day 5. In contrast, stronger STAT1 activation was detected in the allogeneic grafts (L-DA or DA-L), with peak effect occurring 3 days after surgery. Accordingly, expression of STAT1 protein, which is known to be induced by activated STAT1, (24) Next, we also examined the expression of p21 and IRF-1, the genes downstream of STAT1, in the transplanted livers. As shown in Fig. 3C , expression of IRF-1 and p21 was significantly higher in the allogeneic grafts than the syngeneic grafts.
Upregulation of hepatic IFN-mRNA and serum IFN-levels in the allogeneic grafts vs. the syngeneic grafts
To understand the molecular mechanisms by which activation of STAT1 was enhanced while STAT3 was decreased in the allogeneic grafts, we examined the expression of several cytokines in the livers. As shown in Fig. 4A , expression of IFN-H was much higher in the allogeneic grafts compared with the syngeneic grafts. In the L-L group, IFN-mRNA was only significantly induced 5 days after the surgery, while significant elevation of IFN-mRNA expression was observed 2 days after surgery and detected at high levels up to day 7 post-transplant in both L-DA and DA-L groups. Hepatic IL-6 mRNA expression was also induced after OLT, with peak induction on days 2 and 3 post surgery in the syngeneic grafts, consistent with a previous report.(7) Induction of hepatic IL-6 mRNA was greater and prolonged in the L-DA and DA-L groups. Moreover, expression of IL-2 and IL-15 was slightly induced in all 3 groups, with slightly higher expression in the allogeneic grafts than the syngeneic grafts. Hepatic suppressor of cytokine signaling 1 (SOCS1) and SOCS3 mRNA expression were also significantly induced post-transplant in all groups. This expression was slightly higher in the allogeneic grafts vs. the synegenic grafts, which is likely due to higher levels of IFN-and IL-6 expression in the liver (Fig. 4A) since IFN-and IL-6 are responsible for induction of SOCS1 and SOCS3, respectively.
Serum levels of IFN-were elevated 5 days post-OLT in the L-L group, which correlated with peak expression of hepatic IFN-mRNA ( Fig. 4A ) and peak activation of STAT1 (Fig. 3A) in this group. Interestingly, serum IFN-levels were elevated much earlier and higher in the allogeneic groups compared with the syngeneic groups (Fig. 4B ), consistent with a previous report.(32) Higher serum IFN-levels in the allogeneic groups also correlated with higher levels of hepatic IFN-mRNA expression (Fig. 4A ) and STAT1 activation (Fig. 3A) . 5D ). Similarly, expression of IFN-H, IRF-1, and p21 decreased in the NKRP1 antibody-treated groups compared with the IgG-treated groups (Fig. 5E ).
Depletion of NK cells decreases STAT1 activation, but enhances liver regeneration in the allografts
Discussion
In this investigation, we demonstrated that liver injury and apoptosis were higher but hepatocyte proliferation was lower in the allogeneic transplant rats compared with the syngenic transplant rats. Furthermore, we provided evidence suggesting (a) that upregulation of STAT1 activation and downregulation of STAT3 activation likely contribute to enhanced liver injury but suppressed hepatocyte proliferation in the allogeneic grafts compared with the syngenic grafts; (b) upregulation of IFN-production is responsible, at least in part, for stronger STAT1 activation in the allogeneic groups vs. the syngeneic group. NK cells likely contribute to IFN-production. The inhibitory effects of STAT1 in hepatocyte proliferation is mediated partly via induction of IRF-1 and p21 gene expression, followed by induction of cell cycle arrest and apoptosis in hepatocytes. (42) Interestingly, compared with the syngeneic grafts, STAT3 activation was significantly lower while STAT1 was higher in the allogeneic grafts (L-DA or DA-L) (Fig. 3) . Accordingly, the STAT1 downstream genes, IRF-1 and p21, were also upregulated in the allogeneic grafts (Fig. 3) . Taken together, these findings strongly suggest that upregulation of STAT1 and downregulation of STAT3 are likely involved in decreasing hepatocyte proliferation and increasing apoptosis in the allogeneic grafts. Although STAT1 may contribute to decreased hepatocyte proliferation and increased apoptosis in the allogeneic grafts, STAT1 does not contribute to or correlate with the survival rate because STAT1 protein expression was significantly induced in both L-DA (100% survival rate) and DA-L groups (0% survival rate).
Downregulation of STAT3 and upregulation of STAT1 contribute to enhanced liver injury but decreased hepatocyte proliferation in allografts:
Upregulation of IFN-likely contributes to increased STAT1 activation in the synegenic transplant groups.
IFN-H is one of the major cytokines that activate STAT1 in the liver. (14) Here we demonstrated that serum levels of IFN-protein and hepatic IFN-mRNA are much greater in the allogeneic groups vs. the syngeneic group (Fig. 4) , and correlate with STAT1 activation and apoptosis (TUNEL) in the allogeneic grafts. This strongly suggests that higher levels of IFNare responsible for inducing stronger STAT1 activation and apoptosis in the allogeneic group.
Interestingly, the peak level of IFN-did not correlate with the peak level of ALT on day 1 post transplantation in Fig. 1 . This is probably because peak levels of ALT on day 1 were caused by ischemia/reperfusion liver injury and IFN-was not involved. IFN-and activation of STAT1 likely contribute to the apoptosis and elevation of ALT/AST on day 3-7 post transplantation.
Consistent with our findings, higher serum levels of IFN-protein and hepatic IFN-mRNA in the allogeneic transplantation than in the syngeneic group were also previously reported. In contrast to STAT1, activation of STAT3 was suppressed in the allogeneic groups compared with the synegeneic group. The finding that hepatic IL-6, a major cytokine responsible for activating STAT3 in the liver, (14) were higher in the allogeneic groups compared with the synegeneic groups suggest that lower STAT3 activation was not due to lack of IL-6 expression.
Expression of SOCS1 and SOCS3, the two major inhibitor proteins for STAT3, was similar in the allogeneic and syngeneic groups, indicating that decreased STAT3 activation in the former is 
